BENLYSTA is a prescription medicine used to treat people 5 years of age and older with active systemic lupus erythematosus (SLE or lupus) or active lupus nephritis (LN) (lupus-related kidney inflammation) who are receiving other lupus medicines. It is not known if BENLYSTA is safe/effective in people with severe active central nervous system lupus.

​

It is not known if BENLYSTA, given under the skin, is safe/effective in:
 

• children with SLE under 5 years of age or weighing less than 33 lbs

• children with LN under 18 years of age

​

It is not known if BENLYSTA, given in a vein (intravenously), is safe and effective in children less than 5 years of age.